Search

Your search keyword '"Buque, Xabier"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Buque, Xabier" Remove constraint Author: "Buque, Xabier" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
23 results on '"Buque, Xabier"'

Search Results

1. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

2. FRI-472-YI Mitochondrial metabolism is disrupted by ciprofloxacin preventing cholangiocarcinoma cell proliferation

3. THU-210 Dysfunctional activation of the DNA damage response is associated with MASLD progression through an E2F2-dependent mechanism

4. FRI-343-YI APAP induced liver damage is prevented by activation of PPARgamma and PPAR-alpha

5. OS-101-YI Remodelling of hepatocyte cholesterol metabolism mediates colorectal liver metastasis

6. OS-042-YI Metabolic reprogramming induced by pravastatin prevents polycystic liver disease progression improving mitochondrial bioenergetics in cystic cholangiocytes

7. FRI-153 High prevalence of steatotic liver disease and systemic inflammation in hereditary fructose intolerance (HFI) patients independent of age, BMI and the presence of metabolic syndrome

8. TOP-229-YI The E2F2 target glycerophosphodiester phosphodiesterase domain containing 3 is involved in MASLD progression to HCC and related dyslipidemias

9. Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis

10. The E2F2-miR34a-5p axis is involved in the biliary metabolism dysregulation in NASH

11. Targeting the E2F/MCM axis in cholangiocarcinoma halts disease progression in experimental models by rewiring lipid metabolism

12. E2F2 deficiency protects from acetaminophen-induced hepatotoxicity while E2F1 is required to prevent the devastating effects

13. E2F2-promoted DNA damage in NASH worsens the metabolic scenario

14. The uptake of extracellular lipids promotes cholangiocarcinoma progression

15. miR34a-5p is a target of E2F2 transcription factor in MAFLD-related HCC

16. Methionine adenosyltransferase 1a antisense oligonucleotides induce the fibroblast growth factor 21-driven recovery from obesity and associated hepatoesteatosis

17. The DNA damage response is involved in the metabolic dysregulation of MAFLD patients via inefficient fatty acid oxidation

18. Global multi-stakeholder endorsement of the MAFLD definition

19. Global multi-stakeholder endorsement of the MAFLD definition

20. WED-408 - E2F2-promoted DNA damage in NASH worsens the metabolic scenario

21. WED-404 - The E2F2-miR34a-5p axis is involved in the biliary metabolism dysregulation in NASH

22. SAT-215 - Targeting the E2F/MCM axis in cholangiocarcinoma halts disease progression in experimental models by rewiring lipid metabolism

23. FRI-395 - E2F2 deficiency protects from acetaminophen-induced hepatotoxicity while E2F1 is required to prevent the devastating effects

Catalog

Books, media, physical & digital resources